Oncolytics Biotech ONCY
NASDAQ ONCY
$0.41 +0.03 (+7.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Oncolytics Biotech (ONCY) Change in Account Payables (2025 - 2026)

Updated

Oncolytics Biotech (ONCY) recorded Change in Account Payables of $2.93 million in FY2025, compared with $4,000 in FY2024.

Analysis

Oncolytics Biotech (ONCY) Change in Account Payables (2025 - 2026) Analysis & Trends

  • Per Business Quant data, ONCY's Change in Account Payables was $4,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 83.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 254.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Oncolytics Biotech 47.36 Mn 23.68 Mn - 730,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 730,000.00
Mar 31, 2026 -813,000.00
Jun 30, 2025 242,000.00
Mar 31, 2025 112,000.00
API Access

Oncolytics Biotech Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=ONCY&period=max&api_key=YOUR_API_KEY